As of Mar 02
| +1.40 / +2.30%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 55.50, with a high estimate of 72.00 and a low estimate of 38.00. The median estimate represents a -10.76% decrease from the last price of 62.19.
The current consensus among 11 polled investment analysts is to Hold stock in Abiomed Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.